25 results
424B3
MEIP
MEI Pharma Inc
6 Jun 23
Prospectus supplement
4:19pm
requirements could result in a product recall, costly and time-consuming corrective or preventative actions, or prevent commercialization of MEI’sdrug … or take other regulatory or legal enforcement action, including recall or seizure, total or partial suspension of production, suspension of ongoing
8-K
EX-10.1
tfph8mq4cu
16 May 18
MEI Pharma Announces $75 Million Private Placement
5:27pm
424B3
mzevnjxu bw
13 Nov 12
Prospectus supplement
12:00am